 Theodore Randolph
Concepts (530)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 36 | 2025 | 1505 | 6.510 |
Why?
| | Protein Aggregates | 26 | 2023 | 84 | 5.260 |
Why?
| | Freeze Drying | 44 | 2024 | 81 | 4.550 |
Why?
| | Silicone Oils | 15 | 2017 | 37 | 4.120 |
Why?
| | Recombinant Proteins | 54 | 2019 | 1368 | 4.050 |
Why?
| | Particle Size | 42 | 2025 | 381 | 3.970 |
Why?
| | Proteins | 32 | 2022 | 1023 | 3.810 |
Why?
| | Chemistry, Pharmaceutical | 36 | 2021 | 112 | 3.750 |
Why?
| | Drug Stability | 53 | 2025 | 169 | 3.620 |
Why?
| | Immunoglobulin G | 25 | 2025 | 892 | 3.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 14 | 2019 | 253 | 2.790 |
Why?
| | Polysorbates | 24 | 2025 | 42 | 2.780 |
Why?
| | Antibody Formation | 13 | 2017 | 288 | 2.750 |
Why?
| | Excipients | 29 | 2025 | 55 | 2.610 |
Why?
| | Microscopy | 7 | 2025 | 147 | 2.510 |
Why?
| | Ebolavirus | 4 | 2022 | 91 | 2.460 |
Why?
| | Drug Compounding | 19 | 2024 | 107 | 2.450 |
Why?
| | Machine Learning | 7 | 2025 | 587 | 2.390 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2021 | 133 | 2.370 |
Why?
| | Human Growth Hormone | 10 | 2014 | 47 | 2.280 |
Why?
| | Surface-Active Agents | 19 | 2020 | 98 | 2.260 |
Why?
| | Vaccines | 5 | 2024 | 388 | 2.160 |
Why?
| | Muramidase | 13 | 2022 | 67 | 2.100 |
Why?
| | Water | 25 | 2023 | 445 | 2.070 |
Why?
| | Adjuvants, Immunologic | 11 | 2024 | 243 | 1.990 |
Why?
| | Antibodies | 5 | 2023 | 397 | 1.960 |
Why?
| | Adsorption | 24 | 2025 | 153 | 1.940 |
Why?
| | Aluminum Hydroxide | 8 | 2019 | 13 | 1.920 |
Why?
| | Protein Folding | 34 | 2012 | 276 | 1.900 |
Why?
| | Hemorrhagic Fever, Ebola | 3 | 2021 | 82 | 1.800 |
Why?
| | Growth Hormone | 6 | 2016 | 91 | 1.760 |
Why?
| | Nanoparticles | 11 | 2025 | 517 | 1.740 |
Why?
| | Image Processing, Computer-Assisted | 6 | 2025 | 779 | 1.640 |
Why?
| | Protein Conformation | 42 | 2017 | 938 | 1.620 |
Why?
| | Temperature | 29 | 2025 | 633 | 1.560 |
Why?
| | Protein Stability | 29 | 2020 | 176 | 1.460 |
Why?
| | Papillomavirus Vaccines | 3 | 2023 | 296 | 1.430 |
Why?
| | Syringes | 8 | 2019 | 49 | 1.420 |
Why?
| | Viral Vaccines | 3 | 2022 | 107 | 1.380 |
Why?
| | Unsupervised Machine Learning | 3 | 2025 | 23 | 1.290 |
Why?
| | Drug Packaging | 6 | 2020 | 41 | 1.260 |
Why?
| | Mice, Inbred BALB C | 15 | 2025 | 1261 | 1.240 |
Why?
| | Technology, Pharmaceutical | 7 | 2015 | 30 | 1.230 |
Why?
| | Sucrose | 20 | 2019 | 114 | 1.140 |
Why?
| | Stress, Mechanical | 10 | 2023 | 494 | 1.140 |
Why?
| | Glass | 7 | 2019 | 46 | 1.130 |
Why?
| | Thermodynamics | 27 | 2009 | 419 | 1.110 |
Why?
| | Aluminum | 2 | 2024 | 43 | 1.090 |
Why?
| | Microspheres | 6 | 2016 | 142 | 1.080 |
Why?
| | Immunoconjugates | 5 | 2019 | 138 | 1.070 |
Why?
| | Papillomavirus Infections | 2 | 2023 | 344 | 1.060 |
Why?
| | Trehalose | 11 | 2022 | 35 | 1.030 |
Why?
| | Freezing | 17 | 2019 | 83 | 1.010 |
Why?
| | Adjuvants, Pharmaceutic | 4 | 2022 | 15 | 1.010 |
Why?
| | Emulsions | 6 | 2022 | 59 | 0.980 |
Why?
| | Complement Activation | 2 | 2019 | 399 | 0.950 |
Why?
| | Aluminum Oxide | 4 | 2025 | 13 | 0.930 |
Why?
| | Solubility | 19 | 2019 | 240 | 0.930 |
Why?
| | Rabies Vaccines | 1 | 2025 | 3 | 0.920 |
Why?
| | Rabies | 1 | 2025 | 4 | 0.910 |
Why?
| | Surface Properties | 20 | 2023 | 386 | 0.910 |
Why?
| | Delayed-Action Preparations | 5 | 2024 | 189 | 0.890 |
Why?
| | Lipase | 2 | 2025 | 75 | 0.870 |
Why?
| | Serum Albumin | 5 | 2015 | 147 | 0.870 |
Why?
| | Glycoproteins | 3 | 2022 | 354 | 0.860 |
Why?
| | Amyloid | 6 | 2021 | 94 | 0.860 |
Why?
| | Mice | 28 | 2025 | 18329 | 0.830 |
Why?
| | Virion | 2 | 2023 | 108 | 0.800 |
Why?
| | Chromatography, Gel | 15 | 2016 | 130 | 0.780 |
Why?
| | Drug Contamination | 7 | 2019 | 53 | 0.770 |
Why?
| | Capsid | 1 | 2023 | 94 | 0.770 |
Why?
| | Protein Interaction Mapping | 2 | 2016 | 105 | 0.770 |
Why?
| | Colloids | 7 | 2018 | 59 | 0.770 |
Why?
| | Immunologic Factors | 2 | 2019 | 260 | 0.760 |
Why?
| | Root Cause Analysis | 1 | 2022 | 11 | 0.740 |
Why?
| | Bacteriophages | 1 | 2024 | 110 | 0.740 |
Why?
| | Animals | 47 | 2025 | 38030 | 0.740 |
Why?
| | Inclusion Bodies | 4 | 2010 | 27 | 0.720 |
Why?
| | Interferon-gamma | 6 | 2003 | 784 | 0.700 |
Why?
| | Protein Structure, Secondary | 20 | 2014 | 371 | 0.690 |
Why?
| | Hydrogen-Ion Concentration | 19 | 2013 | 531 | 0.680 |
Why?
| | Alphapapillomavirus | 1 | 2021 | 35 | 0.680 |
Why?
| | Immunotherapy, Adoptive | 1 | 2025 | 342 | 0.680 |
Why?
| | Capsid Proteins | 3 | 2021 | 94 | 0.680 |
Why?
| | Bacteriophage lambda | 1 | 2022 | 90 | 0.670 |
Why?
| | Ovalbumin | 2 | 2025 | 194 | 0.660 |
Why?
| | Cell Survival | 1 | 2024 | 1100 | 0.660 |
Why?
| | Antibodies, Viral | 5 | 2025 | 674 | 0.650 |
Why?
| | Recombinant Fusion Proteins | 5 | 2012 | 666 | 0.640 |
Why?
| | Granulocyte Colony-Stimulating Factor | 4 | 2012 | 90 | 0.640 |
Why?
| | Marburgvirus | 1 | 2020 | 21 | 0.640 |
Why?
| | Spectrometry, Fluorescence | 10 | 2021 | 165 | 0.640 |
Why?
| | Biotechnology | 3 | 2010 | 45 | 0.640 |
Why?
| | Hydrostatic Pressure | 8 | 2011 | 29 | 0.630 |
Why?
| | Benzyl Alcohol | 6 | 2011 | 12 | 0.630 |
Why?
| | Fluorescent Dyes | 3 | 2018 | 333 | 0.620 |
Why?
| | Gels | 3 | 2016 | 85 | 0.610 |
Why?
| | Protein Denaturation | 16 | 2015 | 76 | 0.600 |
Why?
| | Polyvinyl Chloride | 1 | 2019 | 12 | 0.600 |
Why?
| | Diethylhexyl Phthalate | 1 | 2019 | 13 | 0.590 |
Why?
| | Drug Storage | 14 | 2021 | 53 | 0.590 |
Why?
| | Sialoglycoproteins | 5 | 2006 | 157 | 0.590 |
Why?
| | Vaccines, Synthetic | 4 | 2025 | 137 | 0.590 |
Why?
| | Ebola Vaccines | 1 | 2019 | 13 | 0.580 |
Why?
| | Stainless Steel | 3 | 2023 | 19 | 0.580 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1996 | 0.550 |
Why?
| | Antigens | 4 | 2024 | 348 | 0.550 |
Why?
| | Benzothiazoles | 2 | 2018 | 39 | 0.550 |
Why?
| | Humans | 85 | 2025 | 145474 | 0.550 |
Why?
| | Osmolar Concentration | 9 | 2016 | 168 | 0.550 |
Why?
| | Spectrophotometry, Infrared | 14 | 2014 | 53 | 0.530 |
Why?
| | Buffers | 12 | 2014 | 56 | 0.530 |
Why?
| | Guanidine | 12 | 2014 | 21 | 0.520 |
Why?
| | RNA, Messenger | 1 | 2025 | 2803 | 0.520 |
Why?
| | Kinetics | 19 | 2010 | 1567 | 0.520 |
Why?
| | Hemoglobins | 6 | 1999 | 386 | 0.520 |
Why?
| | Circular Dichroism | 17 | 2014 | 151 | 0.520 |
Why?
| | Insulin | 3 | 2021 | 2512 | 0.520 |
Why?
| | Protein Structure, Tertiary | 15 | 2015 | 855 | 0.510 |
Why?
| | Antibodies, Neutralizing | 4 | 2025 | 340 | 0.500 |
Why?
| | Scattering, Radiation | 10 | 2012 | 98 | 0.500 |
Why?
| | Solutions | 15 | 2015 | 159 | 0.500 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 145 | 0.490 |
Why?
| | Polyesters | 6 | 2004 | 75 | 0.490 |
Why?
| | Calorimetry, Differential Scanning | 9 | 2015 | 36 | 0.480 |
Why?
| | Complement System Proteins | 1 | 2019 | 314 | 0.480 |
Why?
| | Rheology | 6 | 2019 | 94 | 0.460 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 261 | 0.460 |
Why?
| | Powders | 5 | 2022 | 44 | 0.460 |
Why?
| | Models, Chemical | 6 | 2012 | 250 | 0.450 |
Why?
| | Oncogene Proteins, Viral | 1 | 2015 | 20 | 0.450 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2016 | 592 | 0.440 |
Why?
| | Anthrax Vaccines | 1 | 2015 | 7 | 0.440 |
Why?
| | Escherichia coli | 4 | 2022 | 835 | 0.440 |
Why?
| | Crystallization | 8 | 2019 | 136 | 0.440 |
Why?
| | Lipid A | 1 | 2015 | 27 | 0.430 |
Why?
| | Serum Albumin, Bovine | 3 | 2015 | 62 | 0.430 |
Why?
| | Pressure | 10 | 2009 | 226 | 0.420 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 10 | 2011 | 85 | 0.420 |
Why?
| | Polyethylene Glycols | 10 | 2014 | 649 | 0.420 |
Why?
| | Databases, Factual | 2 | 2017 | 1490 | 0.410 |
Why?
| | Light | 10 | 2012 | 403 | 0.410 |
Why?
| | Pharmaceutical Preparations | 4 | 2018 | 170 | 0.400 |
Why?
| | Flow Cytometry | 2 | 2024 | 1162 | 0.400 |
Why?
| | Ricin | 1 | 2013 | 8 | 0.390 |
Why?
| | Preservatives, Pharmaceutical | 2 | 2011 | 28 | 0.390 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 5 | 2015 | 331 | 0.380 |
Why?
| | Ultraviolet Rays | 3 | 2014 | 384 | 0.380 |
Why?
| | Streptavidin | 2 | 2009 | 15 | 0.380 |
Why?
| | Protein Binding | 17 | 2018 | 2238 | 0.380 |
Why?
| | Polymers | 4 | 2004 | 485 | 0.380 |
Why?
| | Vaccines, Subunit | 1 | 2013 | 53 | 0.380 |
Why?
| | Algorithms | 5 | 2024 | 1845 | 0.370 |
Why?
| | Hydroxyethyl Starch Derivatives | 3 | 2009 | 9 | 0.370 |
Why?
| | Histidine | 2 | 2011 | 66 | 0.370 |
Why?
| | Enzyme Stability | 5 | 2009 | 73 | 0.360 |
Why?
| | Chemical Precipitation | 8 | 2009 | 39 | 0.360 |
Why?
| | Deuterium Exchange Measurement | 2 | 2011 | 26 | 0.350 |
Why?
| | Drug Delivery Systems | 6 | 2011 | 381 | 0.350 |
Why?
| | Urea | 8 | 2018 | 85 | 0.350 |
Why?
| | Peptides | 1 | 2018 | 998 | 0.350 |
Why?
| | Chromatography, Affinity | 1 | 2011 | 80 | 0.350 |
Why?
| | Transition Temperature | 5 | 2014 | 28 | 0.340 |
Why?
| | Mice, Inbred C57BL | 10 | 2017 | 5983 | 0.340 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2012 | 992 | 0.340 |
Why?
| | Static Electricity | 4 | 2020 | 114 | 0.330 |
Why?
| | Carbon Dioxide | 3 | 2004 | 227 | 0.330 |
Why?
| | Abatacept | 4 | 2012 | 56 | 0.330 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2009 | 12 | 0.310 |
Why?
| | Lactic Acid | 4 | 2011 | 295 | 0.300 |
Why?
| | Methionine | 3 | 2012 | 161 | 0.300 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.300 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 5 | 2019 | 192 | 0.300 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2009 | 41 | 0.300 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2021 | 156 | 0.300 |
Why?
| | Trastuzumab | 3 | 2019 | 118 | 0.290 |
Why?
| | Cellulase | 2 | 2006 | 32 | 0.290 |
Why?
| | Botulinum Toxins | 4 | 2010 | 48 | 0.280 |
Why?
| | Pharmaceutical Solutions | 6 | 2014 | 14 | 0.280 |
Why?
| | Viscosity | 4 | 2018 | 92 | 0.280 |
Why?
| | Albumins | 3 | 2013 | 119 | 0.270 |
Why?
| | DNA | 3 | 2023 | 1435 | 0.270 |
Why?
| | Mass Spectrometry | 4 | 2010 | 730 | 0.270 |
Why?
| | Alkaline Phosphatase | 1 | 2009 | 144 | 0.270 |
Why?
| | Female | 17 | 2025 | 78844 | 0.260 |
Why?
| | Interferon-alpha | 3 | 2013 | 193 | 0.260 |
Why?
| | Nanostructures | 3 | 2005 | 105 | 0.260 |
Why?
| | Microscopy, Electron, Scanning | 8 | 2005 | 196 | 0.250 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 838 | 0.250 |
Why?
| | Macrophages, Alveolar | 3 | 2006 | 373 | 0.250 |
Why?
| | Hot Temperature | 7 | 2018 | 396 | 0.250 |
Why?
| | Anilino Naphthalenesulfonates | 4 | 2018 | 10 | 0.250 |
Why?
| | Oils | 2 | 2018 | 22 | 0.250 |
Why?
| | Protein Unfolding | 4 | 2019 | 34 | 0.250 |
Why?
| | Chickens | 5 | 2017 | 179 | 0.240 |
Why?
| | Filtration | 3 | 2014 | 68 | 0.240 |
Why?
| | Surface Tension | 2 | 2023 | 9 | 0.240 |
Why?
| | Quality Control | 3 | 2024 | 161 | 0.240 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2010 | 143 | 0.240 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.240 |
Why?
| | Anhydrides | 1 | 2005 | 19 | 0.230 |
Why?
| | Decanoic Acids | 1 | 2005 | 12 | 0.230 |
Why?
| | Protein Biosynthesis | 1 | 2009 | 452 | 0.230 |
Why?
| | Disulfides | 2 | 2005 | 94 | 0.230 |
Why?
| | Rabies virus | 1 | 2025 | 1 | 0.230 |
Why?
| | Dimerization | 8 | 2014 | 189 | 0.230 |
Why?
| | Immunogenetic Phenomena | 2 | 2016 | 8 | 0.230 |
Why?
| | Quartz Crystal Microbalance Techniques | 1 | 2025 | 7 | 0.230 |
Why?
| | Subtilisins | 2 | 2005 | 9 | 0.220 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2005 | 24 | 0.220 |
Why?
| | Protein Structure, Quaternary | 4 | 2011 | 116 | 0.220 |
Why?
| | Trypsin Inhibitor, Kunitz Soybean | 1 | 2004 | 1 | 0.220 |
Why?
| | Injections, Intramuscular | 1 | 2025 | 146 | 0.220 |
Why?
| | Amyloidosis | 2 | 2002 | 44 | 0.220 |
Why?
| | Injections, Subcutaneous | 2 | 2016 | 170 | 0.220 |
Why?
| | Bacterial Vaccines | 3 | 2009 | 63 | 0.220 |
Why?
| | Phage Therapy | 1 | 2024 | 17 | 0.210 |
Why?
| | Hydrolysis | 1 | 2025 | 197 | 0.210 |
Why?
| | Cattle | 6 | 2015 | 946 | 0.210 |
Why?
| | Platelet Aggregation | 1 | 2005 | 99 | 0.210 |
Why?
| | Bone Cements | 1 | 2024 | 39 | 0.210 |
Why?
| | Supervised Machine Learning | 1 | 2024 | 23 | 0.210 |
Why?
| | Jurkat Cells | 1 | 2024 | 115 | 0.210 |
Why?
| | Green Fluorescent Proteins | 1 | 2025 | 407 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 2028 | 0.200 |
Why?
| | Desiccation | 2 | 2021 | 26 | 0.200 |
Why?
| | Liposomes | 1 | 2025 | 262 | 0.200 |
Why?
| | Ions | 2 | 2002 | 66 | 0.200 |
Why?
| | Vitreous Body | 2 | 2003 | 117 | 0.190 |
Why?
| | Hydrodynamics | 1 | 2023 | 50 | 0.190 |
Why?
| | Fibroblast Growth Factor 10 | 2 | 2013 | 23 | 0.190 |
Why?
| | Bias | 1 | 2024 | 197 | 0.190 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2003 | 196 | 0.190 |
Why?
| | Diffusion | 3 | 2016 | 120 | 0.190 |
Why?
| | Disaccharides | 3 | 2013 | 21 | 0.190 |
Why?
| | Vaccines, DNA | 1 | 2002 | 32 | 0.180 |
Why?
| | Squalene | 1 | 2022 | 8 | 0.180 |
Why?
| | Peroxides | 1 | 2022 | 17 | 0.180 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2019 | 124 | 0.180 |
Why?
| | Lipids | 2 | 2025 | 707 | 0.180 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 499 | 0.170 |
Why?
| | Time Factors | 9 | 2021 | 7123 | 0.170 |
Why?
| | Fatty Acids | 1 | 2025 | 457 | 0.170 |
Why?
| | Gentamicins | 2 | 1998 | 50 | 0.170 |
Why?
| | Primates | 1 | 2022 | 133 | 0.170 |
Why?
| | Metals | 2 | 2013 | 136 | 0.170 |
Why?
| | Subtilisin | 1 | 2000 | 4 | 0.170 |
Why?
| | Coloring Agents | 2 | 2002 | 89 | 0.170 |
Why?
| | Tryptophan | 3 | 2013 | 182 | 0.170 |
Why?
| | Mannitol | 3 | 2019 | 40 | 0.170 |
Why?
| | Immunization | 1 | 2023 | 375 | 0.160 |
Why?
| | Electron Spin Resonance Spectroscopy | 8 | 2000 | 94 | 0.160 |
Why?
| | Laboratories | 1 | 2021 | 110 | 0.160 |
Why?
| | Oxidation-Reduction | 7 | 2012 | 1067 | 0.160 |
Why?
| | Dextrans | 7 | 2000 | 84 | 0.160 |
Why?
| | Spectrophotometry, Ultraviolet | 7 | 2014 | 81 | 0.160 |
Why?
| | Isoniazid | 3 | 2006 | 70 | 0.160 |
Why?
| | Solvents | 4 | 2004 | 112 | 0.160 |
Why?
| | Models, Molecular | 4 | 2016 | 1598 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 848 | 0.160 |
Why?
| | Elasticity | 2 | 2018 | 189 | 0.150 |
Why?
| | Structure-Activity Relationship | 4 | 2011 | 563 | 0.150 |
Why?
| | High-Throughput Screening Assays | 1 | 2022 | 176 | 0.150 |
Why?
| | Silicon Dioxide | 2 | 2015 | 119 | 0.150 |
Why?
| | Complement C5a | 1 | 2019 | 54 | 0.150 |
Why?
| | Complement C4a | 1 | 2019 | 9 | 0.150 |
Why?
| | beta-Lactamases | 1 | 1999 | 53 | 0.150 |
Why?
| | Plasticizers | 1 | 2019 | 18 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1997 | 0.150 |
Why?
| | Complement C3a | 1 | 2019 | 40 | 0.150 |
Why?
| | Thromboplastin | 1 | 1999 | 67 | 0.150 |
Why?
| | Complement Factor B | 1 | 2019 | 106 | 0.140 |
Why?
| | Pharmaceutic Aids | 1 | 1998 | 1 | 0.140 |
Why?
| | Complement C3 | 1 | 2019 | 187 | 0.140 |
Why?
| | Models, Theoretical | 2 | 2018 | 558 | 0.140 |
Why?
| | Calibration | 1 | 2018 | 152 | 0.140 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 408 | 0.140 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2018 | 27 | 0.140 |
Why?
| | Photolysis | 2 | 2018 | 90 | 0.130 |
Why?
| | Dosage Forms | 1 | 1997 | 11 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1507 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2011 | 627 | 0.130 |
Why?
| | Optical Imaging | 1 | 2018 | 61 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2014 | 572 | 0.130 |
Why?
| | Crystallography, X-Ray | 2 | 2009 | 486 | 0.130 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 67 | 0.130 |
Why?
| | Immune Tolerance | 2 | 2017 | 385 | 0.120 |
Why?
| | Viscoelastic Substances | 1 | 2016 | 8 | 0.120 |
Why?
| | Quaternary Ammonium Compounds | 3 | 2006 | 50 | 0.120 |
Why?
| | Suspensions | 1 | 2016 | 28 | 0.120 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2188 | 0.120 |
Why?
| | Immunoproteins | 1 | 2016 | 1 | 0.120 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2017 | 79 | 0.120 |
Why?
| | Software | 1 | 2021 | 680 | 0.120 |
Why?
| | Sodium Dodecyl Sulfate | 2 | 2006 | 25 | 0.120 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1923 | 0.110 |
Why?
| | Electrochemistry | 4 | 2016 | 70 | 0.110 |
Why?
| | Neutralization Tests | 1 | 2015 | 76 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 174 | 0.110 |
Why?
| | Cresols | 1 | 2014 | 4 | 0.110 |
Why?
| | Erythropoietin | 1 | 2015 | 100 | 0.110 |
Why?
| | Phenol | 1 | 2014 | 15 | 0.100 |
Why?
| | Glutathione Disulfide | 2 | 2005 | 30 | 0.100 |
Why?
| | Cricetinae | 2 | 2012 | 305 | 0.100 |
Why?
| | Calorimetry | 2 | 2008 | 69 | 0.100 |
Why?
| | Models, Animal | 1 | 2016 | 393 | 0.100 |
Why?
| | Micropore Filters | 1 | 2014 | 4 | 0.100 |
Why?
| | Insulin Lispro | 1 | 2014 | 42 | 0.100 |
Why?
| | Parvovirus | 1 | 2014 | 13 | 0.100 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2014 | 27 | 0.100 |
Why?
| | Biofouling | 1 | 2014 | 8 | 0.100 |
Why?
| | Insulin Aspart | 1 | 2014 | 30 | 0.100 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2014 | 140 | 0.100 |
Why?
| | Cross Reactions | 1 | 2014 | 130 | 0.100 |
Why?
| | In Vitro Techniques | 4 | 2005 | 1048 | 0.100 |
Why?
| | Immunoglobulin Light Chains | 3 | 2003 | 52 | 0.100 |
Why?
| | Lactates | 1 | 1993 | 82 | 0.100 |
Why?
| | Ferrous Compounds | 1 | 2013 | 25 | 0.100 |
Why?
| | Silicates | 1 | 2012 | 13 | 0.100 |
Why?
| | Epitopes | 1 | 2015 | 473 | 0.100 |
Why?
| | Silicones | 1 | 2012 | 31 | 0.090 |
Why?
| | Sodium Chloride | 4 | 2013 | 138 | 0.090 |
Why?
| | Isoenzymes | 2 | 2001 | 294 | 0.090 |
Why?
| | Boron Compounds | 1 | 2012 | 29 | 0.090 |
Why?
| | Trace Elements | 1 | 2013 | 52 | 0.090 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 83 | 0.090 |
Why?
| | Mice, Nude | 1 | 2014 | 679 | 0.090 |
Why?
| | Carbonic Anhydrases | 1 | 1992 | 12 | 0.090 |
Why?
| | Antitubercular Agents | 2 | 2005 | 208 | 0.090 |
Why?
| | Spectrum Analysis | 3 | 2008 | 85 | 0.090 |
Why?
| | Cholesterol Oxidase | 2 | 1988 | 2 | 0.090 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 2 | 1988 | 8 | 0.090 |
Why?
| | Polystyrenes | 1 | 2011 | 38 | 0.090 |
Why?
| | Phospholipids | 1 | 2013 | 214 | 0.090 |
Why?
| | Biopharmaceutics | 1 | 2011 | 2 | 0.090 |
Why?
| | Spectrophotometry | 2 | 2001 | 58 | 0.090 |
Why?
| | Rats | 4 | 2010 | 5584 | 0.090 |
Why?
| | Interferon-beta | 1 | 2011 | 92 | 0.080 |
Why?
| | Weight Gain | 2 | 2013 | 561 | 0.080 |
Why?
| | Carbohydrates | 4 | 2013 | 66 | 0.080 |
Why?
| | Salts | 2 | 2008 | 35 | 0.080 |
Why?
| | Binding Sites | 3 | 2011 | 1310 | 0.080 |
Why?
| | Hypophysectomy | 1 | 2010 | 12 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2009 | 2129 | 0.080 |
Why?
| | Fermentation | 1 | 2010 | 31 | 0.080 |
Why?
| | Chromatography, Ion Exchange | 1 | 2010 | 57 | 0.080 |
Why?
| | beta-Cyclodextrins | 1 | 2010 | 32 | 0.080 |
Why?
| | Tungsten Compounds | 1 | 2009 | 2 | 0.080 |
Why?
| | Aluminum Compounds | 1 | 2009 | 6 | 0.080 |
Why?
| | Steel | 1 | 2009 | 6 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 2883 | 0.080 |
Why?
| | Microscopy, Atomic Force | 1 | 2010 | 128 | 0.080 |
Why?
| | Phase Transition | 1 | 2009 | 24 | 0.080 |
Why?
| | Computer Simulation | 2 | 2025 | 1003 | 0.070 |
Why?
| | Oxides | 1 | 2009 | 47 | 0.070 |
Why?
| | Bacteriophage T4 | 1 | 2009 | 17 | 0.070 |
Why?
| | Clostridium botulinum | 1 | 2008 | 4 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2010 | 2524 | 0.070 |
Why?
| | Factor XIII | 2 | 1998 | 15 | 0.070 |
Why?
| | Ultracentrifugation | 3 | 2009 | 50 | 0.070 |
Why?
| | Powder Diffraction | 1 | 2008 | 3 | 0.070 |
Why?
| | Immunization, Secondary | 1 | 2009 | 92 | 0.070 |
Why?
| | Biodegradation, Environmental | 2 | 2002 | 75 | 0.070 |
Why?
| | Succinates | 1 | 2008 | 25 | 0.070 |
Why?
| | Protein Renaturation | 2 | 2005 | 4 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 204 | 0.070 |
Why?
| | Molecular Structure | 2 | 2006 | 486 | 0.070 |
Why?
| | Chemical Phenomena | 3 | 2014 | 77 | 0.070 |
Why?
| | Nanotechnology | 1 | 2009 | 114 | 0.070 |
Why?
| | Micelles | 2 | 2005 | 39 | 0.060 |
Why?
| | Molecular Conformation | 1 | 2007 | 141 | 0.060 |
Why?
| | Fractionation, Field Flow | 1 | 2007 | 4 | 0.060 |
Why?
| | Immunoglobulin E | 1 | 2009 | 315 | 0.060 |
Why?
| | Hydrogen | 3 | 2003 | 73 | 0.060 |
Why?
| | Actins | 2 | 2000 | 425 | 0.060 |
Why?
| | Deuterium | 3 | 2003 | 100 | 0.060 |
Why?
| | Congo Red | 2 | 2003 | 8 | 0.060 |
Why?
| | Cholesterol | 1 | 1988 | 408 | 0.060 |
Why?
| | Dithiothreitol | 1 | 2005 | 19 | 0.060 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.060 |
Why?
| | Poliomyelitis | 2 | 2018 | 35 | 0.060 |
Why?
| | Biometry | 1 | 2006 | 66 | 0.060 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 345 | 0.060 |
Why?
| | alpha-Amylases | 1 | 2005 | 11 | 0.060 |
Why?
| | Bacillus | 1 | 2005 | 17 | 0.060 |
Why?
| | Trichoderma | 1 | 2005 | 28 | 0.060 |
Why?
| | Detergents | 1 | 2005 | 43 | 0.060 |
Why?
| | Immunoglobulin Variable Region | 2 | 2003 | 80 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 3 | 2005 | 211 | 0.060 |
Why?
| | Cell Line | 3 | 2006 | 2823 | 0.050 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2004 | 55 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1399 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 368 | 0.050 |
Why?
| | Interleukin-11 | 1 | 2004 | 10 | 0.050 |
Why?
| | Arginine | 1 | 2005 | 264 | 0.050 |
Why?
| | Fluorescence | 3 | 2013 | 159 | 0.050 |
Why?
| | Models, Biological | 2 | 2003 | 1764 | 0.050 |
Why?
| | Nucleic Acid Conformation | 1 | 2007 | 723 | 0.050 |
Why?
| | Tacrine | 1 | 2002 | 2 | 0.050 |
Why?
| | Phenylephrine | 1 | 2002 | 74 | 0.050 |
Why?
| | Methods | 1 | 2002 | 68 | 0.050 |
Why?
| | Tyrosine | 1 | 2003 | 217 | 0.040 |
Why?
| | Male | 5 | 2017 | 72842 | 0.040 |
Why?
| | Time | 1 | 2002 | 84 | 0.040 |
Why?
| | Drug Interactions | 2 | 2004 | 405 | 0.040 |
Why?
| | Models, Statistical | 1 | 2006 | 671 | 0.040 |
Why?
| | L-Selectin | 1 | 2001 | 27 | 0.040 |
Why?
| | Prodrugs | 1 | 2002 | 52 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2001 | 112 | 0.040 |
Why?
| | Borates | 1 | 2000 | 3 | 0.040 |
Why?
| | Chemistry, Physical | 2 | 1997 | 37 | 0.040 |
Why?
| | RNA | 1 | 2007 | 910 | 0.040 |
Why?
| | Myoglobin | 1 | 2000 | 12 | 0.040 |
Why?
| | Drug Design | 1 | 2002 | 175 | 0.040 |
Why?
| | Cytochrome c Group | 1 | 2000 | 43 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 2000 | 82 | 0.040 |
Why?
| | Nerve Growth Factor | 1 | 2000 | 36 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 611 | 0.040 |
Why?
| | Electric Conductivity | 1 | 2000 | 85 | 0.040 |
Why?
| | Bence Jones Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Bacteria | 1 | 2006 | 765 | 0.040 |
Why?
| | Permeability | 1 | 2000 | 169 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 1999 | 11 | 0.040 |
Why?
| | Calcium | 1 | 2005 | 1190 | 0.040 |
Why?
| | Mitosporic Fungi | 1 | 1999 | 6 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2003 | 591 | 0.040 |
Why?
| | Refractometry | 1 | 1999 | 27 | 0.040 |
Why?
| | Hydrogels | 2 | 2021 | 701 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1999 | 216 | 0.030 |
Why?
| | Fungal Proteins | 1 | 1999 | 143 | 0.030 |
Why?
| | Centrifugation | 1 | 2018 | 28 | 0.030 |
Why?
| | Phosphates | 2 | 2010 | 177 | 0.030 |
Why?
| | Copper | 1 | 1999 | 119 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3413 | 0.030 |
Why?
| | Self Administration | 1 | 2018 | 122 | 0.030 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 1999 | 154 | 0.030 |
Why?
| | Potassium Chloride | 1 | 1997 | 40 | 0.030 |
Why?
| | Zinc | 1 | 2000 | 306 | 0.030 |
Why?
| | Interferons | 1 | 1998 | 186 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 172 | 0.030 |
Why?
| | Povidone | 1 | 1996 | 6 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 7202 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2003 | 599 | 0.030 |
Why?
| | Epoetin Alfa | 1 | 2015 | 9 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 350 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 546 | 0.030 |
Why?
| | Rabbits | 3 | 2001 | 652 | 0.030 |
Why?
| | Isoelectric Point | 1 | 2014 | 22 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 429 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 116 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 197 | 0.020 |
Why?
| | Sulfites | 1 | 2013 | 8 | 0.020 |
Why?
| | Acrylamides | 1 | 2013 | 74 | 0.020 |
Why?
| | Poliovirus | 1 | 2013 | 73 | 0.020 |
Why?
| | Cyclic N-Oxides | 2 | 1995 | 32 | 0.020 |
Why?
| | Horses | 3 | 2003 | 226 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2013 | 182 | 0.020 |
Why?
| | Kidney | 1 | 2001 | 1497 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 130 | 0.020 |
Why?
| | Cold Temperature | 1 | 2014 | 206 | 0.020 |
Why?
| | Iodides | 1 | 1992 | 11 | 0.020 |
Why?
| | Guanidines | 1 | 1992 | 39 | 0.020 |
Why?
| | Lung | 1 | 2005 | 4106 | 0.020 |
Why?
| | Absorption | 2 | 2004 | 60 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 2003 | 414 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2011 | 44 | 0.020 |
Why?
| | Interferon beta-1a | 1 | 2011 | 14 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 247 | 0.020 |
Why?
| | Injections | 1 | 2011 | 199 | 0.020 |
Why?
| | Particulate Matter | 1 | 2013 | 326 | 0.020 |
Why?
| | 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2010 | 7 | 0.020 |
Why?
| | Clostridium | 1 | 2009 | 19 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 525 | 0.020 |
Why?
| | Deuterium Oxide | 2 | 1999 | 20 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2008 | 18 | 0.020 |
Why?
| | Alcohol Dehydrogenase | 1 | 1988 | 16 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2009 | 80 | 0.020 |
Why?
| | Rosaniline Dyes | 1 | 2007 | 15 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 1988 | 30 | 0.020 |
Why?
| | Enzymes | 1 | 1988 | 60 | 0.020 |
Why?
| | Peptide Mapping | 1 | 2007 | 62 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2007 | 106 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2005 | 9 | 0.010 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2005 | 10 | 0.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2007 | 179 | 0.010 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2005 | 66 | 0.010 |
Why?
| | Oxidants | 1 | 2006 | 99 | 0.010 |
Why?
| | Prions | 1 | 2006 | 56 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2004 | 25 | 0.010 |
Why?
| | Ultrafiltration | 1 | 2004 | 28 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2005 | 167 | 0.010 |
Why?
| | Molecular Weight | 1 | 2004 | 312 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2005 | 213 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2170 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2005 | 237 | 0.010 |
Why?
| | Cytochromes c | 1 | 2003 | 53 | 0.010 |
Why?
| | Ribonucleases | 1 | 2003 | 48 | 0.010 |
Why?
| | Synucleins | 1 | 2003 | 7 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2003 | 41 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2005 | 638 | 0.010 |
Why?
| | alpha-Synuclein | 1 | 2003 | 45 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 2003 | 206 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 302 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2005 | 728 | 0.010 |
Why?
| | Biological Transport | 1 | 2003 | 424 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 141 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 397 | 0.010 |
Why?
| | Sorbitol | 1 | 2001 | 13 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2002 | 571 | 0.010 |
Why?
| | Betaine | 1 | 2001 | 67 | 0.010 |
Why?
| | Protein Subunits | 1 | 2001 | 229 | 0.010 |
Why?
| | Muscles | 1 | 2001 | 330 | 0.010 |
Why?
| | Chromatography | 1 | 2000 | 27 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 762 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2000 | 387 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 1999 | 169 | 0.010 |
Why?
| | Swine | 1 | 2001 | 825 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2001 | 503 | 0.010 |
Why?
| | Drug Carriers | 1 | 1998 | 136 | 0.010 |
Why?
| | Lactose | 1 | 1996 | 7 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1998 | 145 | 0.010 |
Why?
| | Cysteine | 1 | 1997 | 211 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2003 | 1356 | 0.010 |
Why?
| | Myocardium | 1 | 2001 | 934 | 0.010 |
Why?
| | Fructose | 1 | 1996 | 132 | 0.010 |
Why?
| | Spin Labels | 1 | 1995 | 59 | 0.010 |
Why?
| | Middle Aged | 1 | 1996 | 36215 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2000 | 6447 | 0.000 |
Why?
| | Liver | 1 | 1988 | 1896 | 0.000 |
Why?
|
|
Randolph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|